Stephen C. Glover
Board Member
ZyVersa Therapeutics, Inc. (ZVSA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen C. Glover
Stephen C. Glover is recorded as CEO and Board Member at ZyVersa Therapeutics, Inc. (ZVSA). ZyVersa Therapeutics, Inc. reported in an 8-K filed June 12, 2025 that Stephen C. Glover was appointed Class III director, effective June 11, 2025. ZyVersa Therapeutics, Inc. reported in an 8-K filed December 13, 2022 that Stephen C. Glover was appointed President and Chief Executive Officer. ZyVersa Therapeutics, Inc. reported in an 8-K filed December 13, 2022 that Stephen C. Glover was appointed directors of the Company. Equibles holds 5 filed executive changes naming Stephen C. Glover; each is listed under recent activity with its source filing. The proxy statement of ZyVersa Therapeutics, Inc. reports total compensation of $993,217 for Stephen C. Glover in fiscal 2023, including a base salary of $550,000. Disclosed compensation is on record for 2 fiscal years.
“With respect to Proposal No. 1, stockholders elected the Class III director nominees (Stephen C. Glover and Robert G. Finizio), each to hold office for a term of three years and until a successor is duly elected and qualified.”
“Stephen C. Glover was appointed President and Chief Executive Officer”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-11–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ZyVersa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Peter Wolfe CFO
- Daniel J. O'Connor Board Member
- Gregory Freitag Board Member
- James Sapirstein Board Member
- Katrin Rupalla Board Member
- Min Chul Park, Ph.D. Board Member
- Min-Chul Park Board Member
- Rob G. Finizio Board Member
- Robert Finizio Board Member
- Robert G. Finizio Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | ZyVersa Therapeutics, Inc. (ZVSA) | Co-Founder, Chief Executive Officer President and Chairman | $550,000 | $993,217 |
| 2022 | ZyVersa Therapeutics, Inc. (ZVSA) | Co-Founder, Chief Executive Officer President and Chairman | $450,500 | $1,478,448 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.